temoporfin has been researched along with Cancer of Cervix in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergna, C; Etcheverry, ME; Garavaglia, M; Pasquale, MA; Ponzinibbio, C | 1 |
| Aubertin, K; Boggetto, N; Bonneau, S; Bureau, MF; Clément, O; Gazeau, F; Kolosnjaj-Tabi, J; Luciani, N; Marangon, I; Silva, AK; Wilhelm, C | 1 |
| Gaio, E; Moret, F; Reddi, E; Scheglmann, D | 1 |
| Kostron, H; Krimbacher, E; Marth, C; Zeimet, AG | 1 |
4 other study(ies) available for temoporfin and Cancer of Cervix
| Article | Year |
|---|---|
Photodynamic therapy in 2D and 3D human cervical carcinoma cell cultures employing LED light sources emitting at different wavelengths.
Topics: Cell Survival; Female; HeLa Cells; Humans; Light; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Spheroids, Cellular; Uterine Cervical Neoplasms | 2020 |
Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy.
Topics: Animals; Cell Membrane; Drug Carriers; Female; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Imaging; Magnets; Male; Mesoporphyrins; Mice; Nanostructures; Photosensitizing Agents; Prostatic Neoplasms; Uterine Cervical Neoplasms | 2013 |
Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids.
Topics: Cell Survival; Drug Compounding; Female; HeLa Cells; Humans; Light; Mesoporphyrins; Microscopy, Confocal; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Spheroids, Cellular; Uterine Cervical Neoplasms | 2016 |
Photodynamic therapy for recurrent gynecologic malignancy: a report on 4 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease Progression; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Survival Rate; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 1999 |